Beneath HMGA2 alterations in pleomorphic adenomas: Pathological, immunohistochemical, and molecular insights.

Autor: Alsugair Z; Department of Pathology, Institut de Pathologie Multisite, Hospices Civils de Lyon, Hôpital Lyon Sud, Pierre-Bénite, France., Lépine C; Department of Pathology, CHU Nantes, Nantes, France., Descotes F; Biochemistry and Molecular Biology Department, Hospices Civils de Lyon, Hôpital Lyon Sud, Pierre-Bénite, France., Lanic MD; Pathology Department, Centre Henri Becquerel, INSERM U1245, Université Rouen Normandie, Rouen, France., Pissaloux D; The Unit of Molecular Pathology, INSERM 1052, CNRS 5286 of Cancer Research Center of Lyon, and Team Genetics, Epigenetics and Biology of Sarcomas, Université Claude Bernard Lyon 1, Lyon, France; Biopathology department, Centre Leon Berard, Lyon, France., Tirode F; The Unit of Molecular Pathology, INSERM 1052, CNRS 5286 of Cancer Research Center of Lyon, and Team Genetics, Epigenetics and Biology of Sarcomas, Université Claude Bernard Lyon 1, Lyon, France., Lopez J; Biochemistry and Molecular Biology Department, Hospices Civils de Lyon, Hôpital Lyon Sud, Pierre-Bénite, France; University of Lyon, Université Lyon 1, Lyon, France., Céruse P; University of Lyon, Université Lyon 1, Lyon, France; Department of Oto-Rhino-Laryngology and Head and Neck Surgery, Hospices Civils de Lyon, Hôpital de La Croix Rousse, Lyon, France., Philouze P; University of Lyon, Université Lyon 1, Lyon, France; Department of Oto-Rhino-Laryngology and Head and Neck Surgery, Hospices Civils de Lyon, Hôpital de La Croix Rousse, Lyon, France., Fieux M; University of Lyon, Université Lyon 1, Lyon, France; Department of Oto-Rhino-Laryngology and Head and Neck Surgery, Hospices Civils de Lyon, Hôpital Lyon Sud, Pierre-Bénite, France., Wassef M; Department of Pathology, Hôpital Lariboisière, AP-HP, Paris Diderot University, Paris, France., Baglin AC; Department of Pathology, Hôpital Lariboisière, AP-HP, Paris Diderot University, Paris, France., Mihaela O; Pathology Department, CHU de Strasbourg, Strasbourg, France., Castain C; Pathology Department, CHU de Bordeaux, Bordeaux, France., Sudaka A; Histopathology Department, Centre Antoine Lacassagne, Nice, France., Uro-Coste E; Department of Pathology, Institut Universitaire du Cancer-Oncopole, Toulouse, France., Champagnac A; Biopathology department, Centre Leon Berard, Lyon, France., Costes-Martineau V; Department of Pathology, CHU de Montpellier, Montpellier, France., Laé M; Pathology Department, Centre Henri Becquerel, INSERM U1245, Université Rouen Normandie, Rouen, France., Benzerdjeb N; Department of Pathology, Institut de Pathologie Multisite, Hospices Civils de Lyon, Hôpital Lyon Sud, Pierre-Bénite, France; University of Lyon, Université Lyon 1, Lyon, France; EMR3738, CICLY, Pierre-Bénite, France. Electronic address: nazim.benzerdjeb@chu-lyon.fr.

Publikováno v: Human pathology [Hum Pathol] 2024 Oct; Vol. 152, pp. 105633. Date of Electronic Publication: 2024 Jul 30.

Stomatology-ENT. Brocheriou C, Baglin AC

Autor: Kummer, J

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmc_________::03816054efa7f1b28c89a8c3faad388a
https://europepmc.org/articles/PMC1731385/

[Diagnosis, prognosis and treatment of sinonasal carcinomas (excluding melanomas, sarcomas and lymphomas)].

Autor: Thariat J; Baclesse Cancer Center, Radiation Oncology Department, Caen, France. Electronic address: jthariat@gmail.com., Moya Plana A; Gustave-Roussy Cancer Campus, Head and Neck Surgery Department, Villejuif, France., Vérillaud B; Lariboisière Hospital, Head and Neck Surgery Department, Paris, France., Vergez S; Toulouse University Hospital Center, Head and Neck Surgery Department, Toulouse, France., Régis-Ferrand F; Gustave-Roussy Cancer Campus, Head and Neck Oncology Department, Villejuif, France; HIA Begin, Medical Oncology Department, Saint-Mandé, France., Digue L; Pellegrin Hospital, Centre Michelet, Head and Neck Oncology Department, Bordeaux, France., Even C; Gustave-Roussy Cancer Campus, Head and Neck Oncology Department, Villejuif, France., Costes V; Montpellier Hospital, Department of Pathology, Montpellier, France., Baujat B; Tenon Hospital, Head and Neck Surgery Department, Paris, France., de Gabory L; Lariboisière Hospital, Department of Pathology, Paris, France., Baglin AC; Pellegrin Hospital, Centre Michelet, Head and Neck Surgery Department, Bordeaux, France., Janot F; Gustave-Roussy Cancer Campus, Head and Neck Surgery Department, Villejuif, France.

Publikováno v: Bulletin du cancer [Bull Cancer] 2020 May; Vol. 107 (5), pp. 601-611. Date of Electronic Publication: 2020 Apr 15.

[Diagnostic and treatment pitfalls and guidelines for variants of squamous cell carcinomas of the head and neck: on behalf of the REFCOR].

Autor: Thariat J; Centre François-Baclesse/Archade, département de radiothérapie-oncologie, 3, avenue General-Harris, 14000 Caen, France; Laboratoire de physique corpusculaire IN2P3/ENSICAEN - UMR6534, 14000 Caen, France; Unicaen - Normandie université, 14000 Caen, France. Electronic address: jthariat@gmail.com., Hourseau M; Hôpital Bichat, département d'anatamo-pathologie, 46, rue Henri-Huchard, 75018 Paris, France., Baglin AC; AP-HP, université Paris Diderot, hôpital Lariboisière, département d'anatamo-pathologie, 2, rue Ambroise-Paré, 75475 Paris cedex 10, France., Digue L; Réseau de Cancérologie d'Aquitaine, CHU de Bordeaux, département d'oncologie médicale, 33076 Bordeaux, France., Vulquin N; Centre Georges-François-Leclerc Center, département de radiothérapie, Dijon, France., Badoual C; HEGP, department of pathology, 20 rue Leblanc, 75015 Paris, France., Baujat B; CHU Tenon, department of head and neck surgery, 4 rue de la Chine, 75020 Paris, France., Janot F; Institute Gustave-Roussy, département de cancérologie cervico-faciale-cancer ORL, 114, rue Edouard-Vaillant, 94800 Villejuif, France., Ferrand FR; Hôpital Begin, département d'oncologie médicale, 69, avenue de Paris, 94160 Saint-Mandé, France., Barry B; Hôpital Bichat, département d'oto-rhino-laryngologie (ORL) et chirurgie cervico-faciale, 46 rue Henri-Huchard, 75018 Paris, France.

Publikováno v: Bulletin du cancer [Bull Cancer] 2019 Apr; Vol. 106 (4), pp. 395-403. Date of Electronic Publication: 2019 Mar 13.

Evaluation of the efficacy of adjuvant radiotherapy versus chemoradiotherapy in patients with salivary gland tumors.

Autor: Aral, İpek P.^1,2 ipekpt@hotmail.com, İnan, Gonca A.^1,2, Gökçe, Ezgi², Gani, Zerrin², Ergün, Dilem², Arslan, Nalan², Akinci, Muhammet B.³, Tezcan, Yılmaz^1,2

Publikováno v: Journal of Cancer Research & Therapeutics. Apr-Jun2024, Vol. 20 Issue 3, p850-857. 8p.